blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1470137

EP1470137 - EDG RECEPTOR AGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.07.2010
Database last updated on 25.09.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[2010/10]
Former [2009/36]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
Former [2004/44]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
Inventor(s)01 / BUGIANESI, Robert, L.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / DOHERTY, George, A.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / GENTRY, Amy
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
04 / HALE, Jeffrey, J.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
05 / LYNCH, Christopher, L.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
06 / MILLS, Sander, G.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
07 / NEWAY, William, E., III
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
 [2004/44]
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[N/P]
Former [2006/48]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2004/44]Buchan, Gavin MacNicol
Merck & Co., Inc., European Patent Department, Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date03705779.115.01.2003
[2004/44]
WO2003US01196
Priority number, dateUS20020350000P18.01.2002         Original published format: US 350000 P
[2004/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03062252
Date:31.07.2003
Language:EN
[2003/31]
Type: A1 Application with search report 
No.:EP1470137
Date:27.10.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2003 takes the place of the publication of the European patent application.
[2004/44]
Type: B1 Patent specification 
No.:EP1470137
Date:02.09.2009
Language:EN
[2009/36]
Search report(s)International search report - published on:US31.07.2003
(Supplementary) European search report - dispatched on:EP29.04.2005
ClassificationIPC:C07F9/38, C07F9/572, C07F9/6558, C07D205/04, C07D207/16, C07D403/04, C07D403/12, C07D405/12, C07D409/12, C07D413/10, C07D413/14, A61K31/397, A61K31/40, A61P9/00, A61P21/00
[2005/24]
CPC:
C07D403/04 (EP,US); A61P1/02 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P17/14 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/06 (EP);
A61P27/02 (EP); A61P27/12 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/14 (EP); A61P31/20 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P5/14 (EP);
A61P7/06 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); C07D205/04 (EP,US); C07D207/16 (EP,US);
C07D403/12 (EP,US); C07D405/12 (EP,US); C07D409/12 (EP,US);
C07D413/10 (EP,US); C07D413/14 (EP,US); C07F9/572 (EP,US);
C07F9/65586 (EP,US) (-)
Former IPC [2004/44]C07F9/38
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/44]
Extension statesAL18.08.2004
LT18.08.2004
LV18.08.2004
MK18.08.2004
RO18.08.2004
TitleGerman:EDG-REZEPTORAGONISTEN[2004/44]
English:EDG RECEPTOR AGONISTS[2004/44]
French:AGONISTES DU RECEPTEUR EDG[2004/44]
Entry into regional phase18.08.2004National basic fee paid 
18.08.2004Search fee paid 
18.08.2004Designation fee(s) paid 
18.08.2004Examination fee paid 
Examination procedure05.08.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
15.07.2004Amendment by applicant (claims and/or description)
18.08.2004Examination requested  [2004/44]
18.03.2008Despatch of a communication from the examining division (Time limit: M04)
09.07.2008Reply to a communication from the examining division
19.09.2008Despatch of a communication from the examining division (Time limit: M04)
28.01.2009Reply to a communication from the examining division
06.04.2009Communication of intention to grant the patent
24.07.2009Fee for grant paid
24.07.2009Fee for publishing/printing paid
Opposition(s)03.06.2010No opposition filed within time limit [2010/32]
Fees paidRenewal fee
07.01.2005Renewal fee patent year 03
09.01.2006Renewal fee patent year 04
05.01.2007Renewal fee patent year 05
08.01.2008Renewal fee patent year 06
14.01.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.09.2009
BE02.09.2009
BG02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
IT02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
TR02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
LU15.01.2010
MC31.01.2010
HU03.03.2010
[2012/47]
Former [2012/43]AT02.09.2009
BE02.09.2009
BG02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
IT02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
LU15.01.2010
MC31.01.2010
HU03.03.2010
Former [2012/42]AT02.09.2009
BE02.09.2009
BG02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
IT02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
MC31.01.2010
HU03.03.2010
Former [2012/41]AT02.09.2009
BE02.09.2009
BG02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
IT02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
MC31.01.2010
Former [2011/14]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
IT02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
MC31.01.2010
Former [2011/07]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
IE15.01.2010
MC31.01.2010
Former [2010/48]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
GR03.12.2009
ES13.12.2009
PT04.01.2010
MC31.01.2010
Former [2010/37]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
ES13.12.2009
PT04.01.2010
MC31.01.2010
Former [2010/35]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
DK02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
ES13.12.2009
PT04.01.2010
Former [2010/30]AT02.09.2009
BE02.09.2009
CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
ES13.12.2009
PT04.01.2010
Former [2010/28]BE02.09.2009
CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
ES13.12.2009
PT04.01.2010
Former [2010/24]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
SK02.09.2009
ES13.12.2009
PT04.01.2010
Former [2010/22]CY02.09.2009
CZ02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
ES13.12.2009
PT04.01.2010
Former [2010/20]CY02.09.2009
EE02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
ES13.12.2009
Former [2010/19]CY02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
ES13.12.2009
Former [2010/16]CY02.09.2009
FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
Former [2010/11]FI02.09.2009
NL02.09.2009
SE02.09.2009
SI02.09.2009
Former [2010/10]FI02.09.2009
NL02.09.2009
SE02.09.2009
Former [2010/09]FI02.09.2009
SE02.09.2009
Documents cited:Search[DA]  - IM D-S ET AL, "CHARACTERIZATION OF A NOVEL SPHINGOSINE 1-PHOSPHATE RECEPTOR, EDG-8", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (20000512), vol. 275, no. 19, ISSN 0021-9258, pages 14281 - 14286, XP000939039 [DA] 1-39 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.275.19.14281
International search[AP]US2002042443  (DAY WESLEY W [US], et al)
by applicant   - Protecting Groups in Organic Synthesis, JOHN WILEY & SONS, INC.
    - LAROCK, Comprehensive Organic Transformations, A Guide to Functional Group Preparations, VCH PUBLISHERS, INC.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.